Can Blocking the Orexin System Enhance Sleep's Benefits to Therapeutic Exposure for PTSD?
Phase of Trial: Phase IV
Latest Information Update: 10 Aug 2017
At a glance
- Drugs Suvorexant (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 25 Apr 2017 Planned End Date changed from 1 Mar 2019 to 31 Mar 2021.
- 25 Apr 2017 Planned primary completion date changed from 1 Mar 2019 to 31 Dec 2020.
- 06 Jan 2017 Status changed from not yet recruiting to recruiting.